PPLPHARMA
Piramal Pharma Limited
160.96
-0.27 (-0.17%)
L: 160.5
H: 161.8
Technical Analysis - PPLPHARMA
04 Feb 2026 09:33 AM IST
Lot Size
2625
Pivot Points
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Fibonacci | 156.06 | 158.56 | 160.11 | 162.60 | 165.10 | 166.65 | 169.14 |
| Bollinger band (1,2) | - | 160.63 | 161.06 | 161.06 | 161.06 | 161.49 | - |
Technical Indicator
| Name | Value |
|---|---|
| Adx(14) | 0.00 |
| Rsi(14) | 46.45 |
| Stoch Rsi(14) | 0.97 |
| MACD(12,26) | -4.61 |
| Williams %R | -39.87 |
| ROC | -4.30 |
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA 9 | 155.00 | 157.50 |
| MA 20 | 161.06 | 160.72 |
| MA 50 | 170.44 | 169.70 |
| MA 100 | 183.88 | 179.26 |
| MA 200 | 193.25 | 188.93 |
Pivot Points
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Fibonacci | 142.38 | 148.80 | 152.77 | 159.18 | 165.60 | 169.57 | 175.98 |
| Bollinger band (1,2) | - | 160.63 | 161.06 | 161.06 | 161.06 | 161.49 | - |
Technical Indicator
| Name | Value |
|---|---|
| Adx(14) | 0.00 |
| Rsi(14) | 46.47 |
| Stoch Rsi(14) | 0.97 |
| MACD(12,26) | -4.63 |
| Williams %R | -40.86 |
| ROC | -4.30 |
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA 9 | 155.00 | 157.50 |
| MA 20 | 161.06 | 160.72 |
| MA 50 | 170.44 | 169.94 |
| MA 100 | 185.67 | 176.34 |
| MA 200 | 168.78 | 174.17 |
Pivot Points
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Fibonacci | 142.38 | 148.80 | 152.77 | 159.18 | 165.60 | 169.57 | 175.98 |
| Bollinger band (1,2) | - | 160.73 | 161.16 | 161.16 | 161.16 | 161.59 | - |
Technical Indicator
| Name | Value |
|---|---|
| Adx(14) | 0.00 |
| Rsi(14) | 46.21 |
| Stoch Rsi(14) | 0.97 |
| MACD(12,26) | -4.47 |
| Williams %R | -66.00 |
| ROC | -4.30 |
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA 9 | 155.22 | 157.70 |
| MA 20 | 161.16 | 160.85 |
| MA 50 | 170.48 | 167.88 |
| MA 100 | 170.03 | 169.51 |
| MA 200 | NaN | NaN |






























































































































































































































